Nustar Gp Holdings Llc (NSH) 25.00 $NSH Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nustar Gp Holdings Llc (NSH) 25.00 $NSH

Uptrend Call Working As NuStar Holdings Stock Rises 54.8% (NSH)
Comtex SmarTrend(R) - Tue Jun 07, 12:45PM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 3 months, NuStar Holdings has returned 54.77% as of today's recent price of $26.62.
NSH: 25.00 (-0.44)

NuStar to Participate in the MLPA 2016 MLP Investor Conference
BusinessWire - Tue May 31, 1:35PM CDT
NuStar Energy L.P. (NYSE: NS) and NuStar GP Holdings, LLC (NYSE: NSH) announced today that President and Chief Executive Officer Brad Barron and Executive Vice President and Chief Financial Officer Tom Shoaf will participate in meetings with members of the investment community at the MLPA 2016 MLP Investor Conference in Orlando, FL on Wednesday, June 1, 2016 and Thursday, June 2, 2016. The materials to be discussed in the meetings will be available on both companies' Web sites at 1:00 p.m. Eastern time, Wednesday, June 1, 2016.
NS: 50.39 (-0.88), NSH: 25.00 (-0.44)

Uptrend Call Working As NuStar Holdings Stock Rises 45.0% (NSH)
Comtex SmarTrend(R) - Tue May 31, 12:22AM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 3 months, NuStar Holdings has returned 45.00% as of today's recent price of $24.94.
NSH: 25.00 (-0.44)

The Zacks Analyst Blog Highlights: Hercules Offshore, Independence Contract Drilling, Contango Oil & Gas, World Point Terminals and NuStar GP Holdings
Zacks Equity Research - Zacks Investment Research - Wed May 25, 8:30AM CDT
The Zacks Analyst Blog Highlights: Hercules Offshore, Independence Contract Drilling, Contango Oil & Gas, World Point Terminals and NuStar GP Holdings
HERO: 1.21 (-0.06), MCF: 12.82 (+0.01), WPT: 15.14 (-0.05), ICD: 5.19 (+0.14), NSH: 25.00 (-0.44)

Crude Heading Toward $50: Buy 5 Low-Levered Oil Stocks
Zacks Equity Research - Zacks Investment Research - Tue May 24, 1:38PM CDT
Against the bullish backdrop for oil, investors can pick low leverage companies with good fundamentals to outperform the market.
HERO: 1.21 (-0.06), GS: 148.63 (-1.26), MCF: 12.82 (+0.01), WPT: 15.14 (-0.05), ICD: 5.19 (+0.14), NS: 50.39 (-0.88), NSH: 25.00 (-0.44), CVX: 102.10 (+0.12)

Shares of NSH Up 46.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon May 23, 12:48PM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 3 months, NuStar Holdings has returned 46.34% as of today's recent price of $25.17.
NSH: 25.00 (-0.44)

NuStar Holdings Shares Up 44.8% Since SmarTrend's Buy Recommendation (NSH)
Comtex SmarTrend(R) - Fri May 13, 12:57PM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 2 months, NuStar Holdings has returned 44.80% as of today's recent price of $24.91.
NSH: 25.00 (-0.44)

Diamond Offshore (DO) Beats on Q1 Earnings, Appoints CFO
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:24AM CDT
Diamond Offshore Drilling Inc. (DO) reported first-quarter 2016 adjusted earnings of 64 cents per share that comfortably surpassed the Zacks Consensus Estimate of 28 cents.
DO: 24.28 (-0.04), BAK: 11.30 (-0.16), NSH: 25.00 (-0.44), PTR: 69.15 (-1.78)

NuStar Holdings Has Returned 49.6% Since SmarTrend Recommendation (NSH)
Comtex SmarTrend(R) - Thu Apr 28, 1:05PM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 2 months, NuStar Holdings has returned 49.59% as of today's recent price of $25.73.
NSH: 25.00 (-0.44)

NuStar GP Earnings Remain Rock-Solid
Matthew DiLallo, The Motley Fool - Motley Fool - Wed Apr 27, 12:31PM CDT
Image source: Flickr user Alexis Madrigal. The deep downturn in the energy market is causing the midstream sector to make changes, with many MLPs choosing to reduce their generous payouts. That same fate, however, isn't something that NuStar GP  ...
NS: 50.39 (-0.88), NSH: 25.00 (-0.44)

NuStar GP Holdings, LLC Reports Earnings for the First Quarter of 2016
BusinessWire - Wed Apr 27, 5:30AM CDT
NuStar GP Holdings, LLC (NYSE: NSH) today announced first quarter 2016 net income of $16.7 million, or $0.39 per unit. Distributable cash flow (DCF) available to unitholders for the first quarter of 2016 was $23.1 million, or $0.54 per unit.
NSH: 25.00 (-0.44)

NuStar Holdings Has Returned 33.8% Since SmarTrend Recommendation (NSH)
Comtex SmarTrend(R) - Tue Apr 19, 12:45AM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 2 months, NuStar Holdings has returned 33.78% as of today's recent price of $23.01.
NSH: 25.00 (-0.44)

NuStar Energy L.P. and NuStar GP Holdings, LLC Reschedule Announcement of First Quarter 2016 Earnings Results to 8:30 a.m. Central Time on April 27, 2016
BusinessWire - Wed Apr 13, 11:20AM CDT
NuStar Energy L.P. (NYSE: NS) and NuStar GP Holdings, LLC (NYSE: NSH) have rescheduled a joint conference call to discuss the first quarter 2016 earnings results. The call will now be on Wednesday, April 27, 2016 at 8:30 a.m. Central Time, with the results to be released earlier that day. The conference call may be accessed by dialing 877/702-5019, reservation passcode 84039576. International callers may access the conference call by dialing 443/863-7314, reservation passcode 84039576. The companies intend to have a playback available following the conference call, which may be accessed by calling 800/585-8367, reservation passcode 84039576. International callers may access the playback by calling 404/537-3406, reservation passcode 84039576.
NS: 50.39 (-0.88), NSH: 25.00 (-0.44)

NuStar Holdings Shares Up 20.3% Since SmarTrend's Buy Recommendation (NSH)
Comtex SmarTrend(R) - Fri Apr 01, 1:53PM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 1 month, NuStar Holdings has returned 20.35% as of today's recent price of $20.70.
NSH: 25.00 (-0.44)

NuStar Energy L.P. and NuStar GP Holdings, LLC to Announce First Quarter 2016 Earnings Results on April 27, 2016
BusinessWire - Fri Apr 01, 11:30AM CDT
NuStar Energy L.P. (NYSE: NS) and NuStar GP Holdings, LLC (NYSE: NSH) today announced that they will host a joint conference call on Wednesday, April 27, 2016 at 9:00 a.m. Central Time to discuss the first quarter 2016 earnings results, which will be released earlier that day. The conference call may be accessed by dialing 877/702-5019, reservation passcode 84039576. International callers may access the conference call by dialing 443/863-7314, reservation passcode 84039576. The companies intend to have a playback available following the conference call, which may be accessed by calling 800/585-8367, reservation passcode 84039576. International callers may access the playback by calling 404/537-3406, reservation passcode 84039576.
NS: 50.39 (-0.88), NSH: 25.00 (-0.44)

Shares of NSH Up 31.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 23, 1:18AM CDT
SmarTrend identified an Uptrend for NuStar Holdings (NYSE:NSH) on March 1st, 2016 at $17.20. In approximately 3 weeks, NuStar Holdings has returned 31.80% as of today's recent price of $22.67.
NSH: 25.00 (-0.44)

NuStar GP Holdings, LLC's 2015 Schedule K-1 Tax Packages Now Available
BusinessWire - Thu Mar 03, 8:48AM CST
NuStar GP Holdings, LLC (NYSE: NSH) today announced that the 2015 tax packages, which include the Schedule K-1, are available online at www.nustargpholdings.com in the Investors section of the Web site. The company expects to begin mailing the 2015 tax packages on Friday, March 4, 2016. For additional information, NuStar GP Holdings, LLC unitholders may call K-1 Tax Package Support toll free at (877) 804-9545 weekdays between 8 a.m. and 5 p.m. CT.
NSH: 25.00 (-0.44)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading